CVE-2021-40110

Apache James IMAP vulnerable to a ReDoS

Description

In Apache James, using Jazzer fuzzer, we identified that an IMAP user can craft IMAP LIST commands to orchestrate a Denial Of Service using a vulnerable Regular expression. This affected Apache James prior to 3.6.1 We recommend upgrading to Apache James 3.6.1 or higher , which enforce the use of RE2J regular expression engine to execute regex in linear time without back-tracking.

7.5
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 2.10% Top 20%
Third-Party Advisory openwall.com Third-Party Advisory openwall.com
Affected: Apache Software Foundation Apache James
Published at:
Updated at:

References

Link Tags
https://www.openwall.com/lists/oss-security/2022/01/04/2 third party advisory mailing list
http://www.openwall.com/lists/oss-security/2022/01/04/2 third party advisory mailing list

Frequently Asked Questions

What is the severity of CVE-2021-40110?
CVE-2021-40110 has been scored as a high severity vulnerability.
How to fix CVE-2021-40110?
To fix CVE-2021-40110, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-40110 being actively exploited in the wild?
It is possible that CVE-2021-40110 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-40110?
CVE-2021-40110 affects Apache Software Foundation Apache James.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.